Fragile X syndrome

Genetic Foundations: X and Y Chromosome Pathologies

In medical genetics, special attention is paid to the loci of sex chromosomes. Fragile X syndrome belongs to the group of severe neurological and genetic syndromes where the gene is localized directly on the X chromosome.

In addition to this syndrome, the X chromosome carries loci responsible for a number of other systemic pathologies:

• Musculoskeletal and skin disorders: these include Duchenne muscular dystrophy, Kennedy's spinal and bulbar muscular atrophy, ichthyosis, chondrodysplasia punctata, and hypohidrotic epidermal dysplasia.
• Visual impairments: mutations in the corresponding loci can cause color blindness and retinitis pigmentosa.
• Metabolic and hormonal defects: glucose-6-phosphate dehydrogenase deficiency, Lesch-Nyhan syndrome, and androgen receptor defect (known clinically as Morris syndrome, or TFM).
• Hematologic and immune disorders: hemophilia A and hemophilia B, Bruton's agammaglobulinemia, as well as a specific immunodeficiency accompanied by elevated IgM levels.

At the same time, the Y chromosome contains critical regions, among which the spermatogenesis factor and the SRY gene (TDF) stand out, the mutation of which leads to the development of gonadal dysgenesis.

Systemic Fragility: Geriatric Asthenia Syndrome

The term "fragility" applies not only to chromosomes, but also to the general state of the organism. Geriatric asthenia syndrome (frailty phenotype, or frail phenotype) represents a critical reduction in physiological reserve and the loss of the body's ability to adequately maintain homeostasis.

The main consequence of this condition is an extremely heightened sensitivity of the patient to any stress and an extremely high risk of developing complications. For the accurate diagnosis of this syndrome in clinical practice, strictly objective criteria and specialized scales are used to calculate the frailty index and the trauma-specific frailty index.

An integral part of the frailty phenotype is sarcopenia (sarcopenia), an age-related atrophic and degenerative change in skeletal muscle, often accompanied by weight loss. The correction of sarcopenia requires a comprehensive approach that necessarily includes the implementation of exercise programs and adequate nutritional support, i.e., nutrition supplementation.

Clinical Management of Patients with the Frailty Phenotype

Management of patients with geriatric asthenia syndrome requires special attention to detail and minimization of risks. A crucial direction is combating polypharmacy. Physicians must make active efforts to reduce the number of simultaneously prescribed medications to minimize the risk of adverse events associated with pharmacotherapy.

An obligatory step is the assessment of sensory functions. Patients should be regularly screened for vision and hearing impairments. The risks of sensory deficit are extremely high: decreased vision and hearing directly lead to an increased frequency of falls and profound social isolation.

When planning medical interventions in such patients, a strict algorithm is applied:

1. The probability of benefit from the planned intervention is assessed, with mandatory consideration of comorbid pathology and the severity of the "frailty" syndrome.
2. If clinical symptoms are present, but the intervention will not be beneficial, the patient is prescribed exclusively conservative drug therapy.
3. If symptoms are present and the intervention is likely to be beneficial, the patient is referred for a specialized Heart Team evaluation (Heart Team).
4. In cases where symptoms are absent, the algorithm prescribes proceeding to a detailed assessment of left ventricular function.

In traumatology, a staged treatment strategy—damage control orthopaedics (Damage Control Orthopaedics)—is applied for such patients.

Class and exam questions

What else to study on this topic

• Mechanisms of gonadal dysgenesis development in SRY (TDF) gene mutations on the Y chromosome.
• Pathogenesis of musculoskeletal pathologies: Duchenne myopathy and Kennedy muscular dystrophy.
• Metabolic disorders in androgen receptor defects (Morris syndrome) and Lesch-Nyhan syndrome.
• Objective criteria and scales for calculating the frailty index.
• Principles of damage control orthopaedics in trauma.
• Algorithms for combating polypharmacy to minimize adverse events of drug therapy.

Other topics in the "Additional Topics" section

Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.